Markets:

Overview

News

Currencies

International

Treasuries

Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

0.5164 +0.1491 (+40.59%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sunshine Biopharma Inc. - Common stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Sunshine Biopharma Sees Potential Multi-Billion Dollar Global Market Opportunity As Research Findings Reveal Effectiveness Against Multidrug-Resistant Cancer Cells ↗

April 06, 2022

Photo by Angiola Harry on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Via Benzinga

21 Stocks Moving in Wednesday's Pre-Market Session ↗

April 06, 2022

Gainers Dakota Gold (NYSE: DC) shares rose 97.1% to $13.60 in pre-market trading. The company’s stock was uplisted to NYSE American on Tuesday. BigBear.ai Holdings,...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 150 Points; Cognyte Software Shares Drop ↗

April 05, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 150 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 05, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7...

Via Benzinga

51 Biggest Movers From Yesterday ↗

April 06, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...

Via Benzinga

Sunshine Biopharma Stock Triples on Positive mRNA Cancer Treatment Results ↗

April 05, 2022

SBFM stock tripled to $6.53 on Tuesday after revealing that two of its newly designed mRNA molecules are effective in destroying cancer cells.

Via InvestorPlace

Mid-Day Market Update: Dow Dips Over 100 Points; Sunshine Biopharma Shares Surge ↗

April 05, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 100 points on Tuesday.

Via Benzinga

30 Stocks Moving In Tuesday's Mid-Day Session ↗

April 05, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 139% to $5.40 after the company announced that two of its designed mRNA molecules are effective at destroying...

Via Benzinga

Dear NIO Stock Fans, Pay Attention to This HUGE Catalyst ↗

April 05, 2022

Nio (NIO) stock may not be doing so hot on Tuesday but reports of a major catalyst could turn that around in the near future.

Via InvestorPlace

Why Is Sunshine Biopharma (SBFM) Stock Up Today? ↗

April 05, 2022

Sunshine Biopharma (SBFM) stock is shining brighter on Tuesday after revealing the effects its mRNA molecules have against cancer.

Via InvestorPlace

Mid-Morning Market Update: Markets Mixed; ISM Services PMI Rises To 58.3 In March ↗

April 05, 2022

U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping around 150 points on Tuesday.

Via Benzinga

Sunshine Biopharma Shares Are Soaring: Here's Why ↗

April 05, 2022

Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading significantly higher Tuesday after the company announced that two of its designed mRNA molecules are effective at...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 05, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares moved upwards by 163.3% to $5.95 during Tuesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

EXCLUSIVE: Sunshine Biopharma's Newly Designed mRNA Molecules Effective Against Multidrug Resistant Cancer Cells ↗

April 05, 2022

Oncology and antiviral drugs focused Sunshine Biopharma Inc (NASDAQ: SBFM) has said that two of its newly designed mRNA molecules can effectively destroy cancer cells grown in culture.

Via Benzinga

Sunshine Biopharma's $8 Million Private Placement Injects New Funding For Drug Development ↗

March 24, 2022

Image provided by the National Cancer Institute on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing...

Via Benzinga

45 Stocks Moving In Friday's Mid-Day Session ↗

March 18, 2022

Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) jumped 62.4% to $1.5500. DiDi Global Inc. (NYSE: DIDI) shares climbed 46% to $3.73. Kidpik Corp. (NASDAQ: PIK) shares...

Via Benzinga

58 Biggest Movers From Friday ↗

March 21, 2022

Gainers BEST Inc. (NYSE: BEST) shares gained 73.6% to close at $1.00. DiDi Global Inc. (NYSE: DIDI) shares jumped 59.8% to settle at $4.09 on Friday. Zhihu Inc. (NYSE: ZH)...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 18, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) stock increased by 15.5% to $3.5 during Friday's pre-market session. The company's market cap stands at $15.6 million....

Via Benzinga

25 Stocks Moving in Friday's Pre-Market Session ↗

March 18, 2022

Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) rose 60.5% to $1.53 in pre-market trading. StoneCo Ltd. (NASDAQ: STNE) shares rose 23.7% to $11.90 in pre-market trading...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 16, 2022

Gainers

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

March 15, 2022

Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 16, 2022

Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...

Via Benzinga

Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc. (NASDAQ: SBFM)

March 15, 2022

NEW YORK, NY / ACCESSWIRE / March 15, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc. (NASDAQ:SBFM) About Sunshine...

From Aegis Capital Corp.

Via AccessWire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 14, 2022

Gainers Sigilon Therapeutics (NASDAQ:SGTX) stock rose 15.5% to $1.49 during Monday's after-market session. The market value of their outstanding shares is at $48.1 million.

Via Benzinga

Sunshine Biopharma, Inc. Announces Pricing of $8 Million Private Placement Priced At-the-Market ↗

March 14, 2022

Photo by Scott Graham on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 10, 2022

Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 14.8% to $1.55 during Thursday's after-market session. The company's market cap stands at $92.4 million. As per the press release, Q4...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 10, 2022

Gainers Salarius Pharmaceuticals (NASDAQ:SLRX) stock moved upwards by 31.4% to $0.49 during Thursday's regular session. The current volume of 2.4 million shares is 738...

Via Benzinga

50 Stocks Moving In Friday's Mid-Day Session ↗

March 11, 2022

Gainers Marygold Companies (NYSE: MGLD) jumped 189.4% to $6.28 after dropping 21% on Thursday. Altamira Therapeutics Ltd. (NASDAQ: CYTO) shares rose 63.5% to $1.13....

Via Benzinga

78 Biggest Movers From Yesterday ↗

March 11, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday. AgriFORCE Growing Systems, Ltd. (...

Via Benzinga

45 Stocks Moving In Thursday's Mid-Day Session ↗

March 10, 2022

Gainers CEA Industries Inc. (NASDAQ: CEAD) shares surged 33.4% to $2.7350 after the company reported it signed a $2.1 million contract. Yield10 Bioscience, Inc. (NASDAQ: YTEN)...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.